
Hi Reader,
Welcome to The Axtria Collective!
February 28 marks Rare Disease Day, a global initiative to raise awareness for the millions of patients navigating unique healthcare challenges and to emphasize the importance of continued research and innovation in rare disease treatments. This edition of The Axtria Collective features an article on how real-world data is advancing rare disease treatments.
This edition also includes insights on Axtria Rapid CSR, a guide to sales performance management, and a new Gartner® report on how AI is redefining the life sciences industry.
Happy reading!
FEATURED CONTENT

Predicts 2025: CIOs Prepare for AI to Reshape Life Sciences
Receive a complimentary copy of a new Gartner® report that discusses how AI continues to redefine the life sciences industry and presents new challenges and opportunities that impact your journey from "promise to practice."
UPCOMING WEBINAR
.jpg?width=750&height=750&name=Maximizing%20commercial%20performance%20by%20harnessing%20RWD%20and%20Clinical%20data%20(1).jpg)
Maximizing Commercial Performance by Harnessing RWD and Clinical Data
Join us on Wednesday, March 26, at 1:00 PM ET for our upcoming Axtria Ignite webinar, where we’ll discuss how pharmaceutical companies can maximize commercial performance by leveraging insights from RWD and late-phase clinical study data. This drives strategic value - unlocking new patient segments, supporting label expansions, and strengthening payer negotiations with data-driven evidence.
LEADERS' PERSPECTIVES

Accelerating Clinical Study Reporting with AI: Axtria Rapid CSR
In this article published in Pharmaphorum, Luke Dunlap, Principal and Head of Clinical Solutions at Axtria Inc., discusses how Axtria Rapid CSR, a GenAI-powered innovative solution designed to transform clinical study report (CSR) generation, delivers CSRs with 30%–50% faster turnarounds and substantial cost savings.
TIMELESS INSIGHTS

Cell & Gene Therapies for Rare Diseases: Unlocking New Possibilities with Real-World Data
Advances in cell and gene therapies are opening new possibilities for treating rare diseases by targeting a disease’s genetic roots. This article explores how real-world data (RWD) plays a pivotal role in bringing these treatments to patients faster by reshaping patient identification, clinical trial design, and regulatory decision-making.
INDUSTRY PRIMER
Optimizing Sales Excellence: A Comprehensive Guide to Sales Performance Management
Effective Sales Performance Management (SPM) goes beyond incentive compensation—it aligns sales teams with business goals, optimizes territory coverage, and boosts motivation through data-driven insights. This guide explores how life sciences companies can design end-to-end SPM programs to enhance sales productivity, improve operational efficiency, and maximize business outcomes.
NEWS CAPSULE
Winter Release Notes for Axtria DataMAx™ and Axtria SalesIQ™
Axtria has published the Winter 2024 release notes for Axtria DataMAx™ and Axtria SalesIQ™. Explore them to learn about the latest product features, innovations, and enhancements.